The Chicago Entrepreneur

IPO Report: Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion

Kenvue’s stock was cheered in its Wall Street debut Thursday, as the J&J spinoff saw its stock open 16.0% above where the initial public offering was priced.

Previous post In One Chart: Why a plunging 2-year Treasury yield may be screaming Fed ‘policy mistake’
Next post : First Horizon CEO says the bank ‘never assumed regulatory approval was a given’ in scuttled TD merger